AI: DeepSeek (deepseek-chat)

Q: {
  "prompt": "Please analyze the clinical note against the provided guideline and suggest improvements to better align with the guideline recommendations.\n\nFor each recommendation, specify:\n1. The type of recommendation:\n   - Additional information needed (history/examination/investigations)\n   - Improved patient advice (options/statistics/patient information)\n   - Different management plan\n2. The specific recommendation\n3. The reason for the recommendation (referencing the guideline)\n\nCategorize each recommendation by importance:\n- Very Important: Critical for patient safety or guideline compliance\n- Somewhat Important: Significant for optimal care but not critical\n- Less Important: Would improve care but not essential\n- Unimportant: Minor suggestions that could be considered\n\nFormat the response as follows:\n\n### Very Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Somewhat Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Less Important Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\n### Unimportant Recommendations\n[Type] - [Specific recommendation]\nReason: [Reference to guideline ID and relevant section]\n\nClinical Note:\n### **Medical Clerking – SBAR Format**  \n\n#### **SITUATION:**  \n**Patient:** 32-year-old **G3P2** (2 SVD, 0 miscarriages) **AFAB** presenting with **chronic pelvic pain (CPP)** for **6+ months**, worsening over the last **4 weeks**. Pain is **dull, intermittent**, localized to **lower quadrants (LQ > RQ)**, **radiating to lower back**, **exacerbated by menstruation and intercourse (dyspareunia)**. No acute red flags (e.g., hemodynamic instability, peritonism). Last menstrual period **(LMP) 10 days ago**, regular cycles **(28/5)**.  \n\n#### **BACKGROUND:**  \n- **PMHx:**  \n  - **Endometriosis** (diagnosed **laparoscopically 2019**, **Stage II**, treated with **COCP** until 2022)  \n  - **Recurrent PID** (last episode **2021**, treated with **doxycycline + metronidazole**)  \n  - **Chronic IBS** (managed with **dietary modifications + mebeverine PRN**)  \n- **ObHx:**  \n  - **2 uncomplicated term vaginal deliveries** (2017, 2020)  \n  - **No Hx of ectopic pregnancy, fibroids, or ovarian cysts**  \n- **Surgical Hx:**  \n  - **Laparoscopic excision of endometriotic deposits (2019)**  \n  - **Appendectomy (2015)**  \n- **Medications:**  \n  - **Ibuprofen 400mg TDS PRN** (partial relief)  \n  - **COCP (Microgynon 30) until 2022** (discontinued due to **migraine with aura**)  \n  - **Mebeverine 135mg TDS PRN**  \n- **Allergies:** **Nil known drug allergies (NKDA)**  \n- **Social:** **Non-smoker, occasional ETOH, works as office admin, in stable relationship**  \n\n#### **ASSESSMENT:**  \n- **Vitals (at 1430 hours):**  \n  - **BP 118/76 mmHg, HR 72 bpm, SpO₂ 98% RA, Temp 36.8°C**  \n  - **BMI 24.2**  \n- **Examination:**  \n  - **Abdomen:** Soft, non-distended, **tenderness LQ**, no guarding/rebound, **no palpable masses**  \n  - **PV exam:** **No vaginal discharge**, **cervix appears normal**, **no cervical excitation**, **uterine tenderness**, **adnexa non-tender**, **no palpable masses**  \n- **Investigations:**  \n  - **Recent USS (2 weeks ago):** **No adnexal masses, normal endometrial thickness (6mm), no free fluid**  \n  - **FBC (today):** **Hb 12.8 g/dL, WBC 6.2 x10⁹/L, Plt 245 x10⁹/L**  \n  - **CRP:** **<5 mg/L**  \n  - **LFTs/U&Es:** **Normal**  \n  - **High vaginal swab (awaiting results):** **Sent for MC&S, chlamydia/gonorrhoea NAAT**  \n  - **Urine β-hCG:** **Negative**  \n- **Differential Diagnosis:**  \n  1. **Endometriosis recurrence** (given Hx, cyclical pain, dyspareunia)  \n  2. **Chronic pelvic inflammatory disease (PID)** (given recurrent PID Hx)  \n  3. **Adenomyosis** (worsening dysmenorrhea, uterine tenderness)  \n  4. **Pelvic congestion syndrome** (chronic dull ache, postural exacerbation)  \n  5. **Musculoskeletal (e.g., pelvic floor dysfunction, nerve entrapment)**  \n\n#### **RECOMMENDATION:**  \n1. **Immediate Management:**  \n   - **Analgesia:** **Paracetamol 1g QDS + NSAID (naproxen 500mg BD) PRN**  \n   - **Consider trial of hormonal suppression** (e.g., **progestogen-only pill (POP) or Mirena IUS**) given **contraindication to COCP**  \n   - **Pelvic physio referral** (if musculoskeletal component suspected)  \n2. **Investigations:**  \n   - **Repeat TV USS if pain persists** (assess for **adenomyosis, deep infiltrating endometriosis**)  \n   - **Consider diagnostic laparoscopy if refractory** (gold standard for endometriosis)  \n   - **MRI pelvis if deep endometriosis suspected**  \n3. **Follow-Up:**  \n   - **Gynae clinic in 4/52** for reassessment  \n   - **If HVS positive for infection: treat with abx per sensitivities**  \n   - **If persistent pain: MDT discussion (pain team, gynae, physio)**  \n4. **Patient Counselling:**  \n   - **Advise on pain diary (timing, triggers, severity)**  \n   - **Discuss long-term options (e.g., GnRH analogues if severe endometriosis)**  \n\n**Plan documented by: Dr. [Name], FY2**  \n**Time: 1530 hours**  \n**For: Consultant Gynaecology Review**  \n\n*(This is a fictional case for educational purposes only.)*\n\nGuideline:\n[ID] nice-guidance-2024-endometriosis-pdf\nTitle: NICE Guidance - 2024 - Endometriosis.pdf\nContent: Endometriosis: diagnosis and management \nNICE guideline \nPublished: 6 September 2017 \nLast updated: 16 April 2024 \n\nThe recommendations in this guideline represent the view of NICE, arrived at after careful consideration of the evidence available. Professionals and practitioners are expected to take this guideline fully into account, alongside the individual needs, preferences, and values of their patients. \n\n1.1 Organisation of care \n1.2 Endometriosis information and support \n1.3 Endometriosis symptoms and signs \n1.4 Referral for women with suspected or confirmed endometriosis \n1.5 Diagnosing endometriosis \n1.6 Staging systems \n1.7 Monitoring for women with confirmed endometriosis \n1.8 Pharmacological pain management \n1.9 Non-pharmacological management \n1.10 Surgical management \n1.11 Management if fertility is a priority \n\nTerms used in this guideline \n\nRecommendations for research \n\nOverview \nWho is it for? \nRationale and impact \nContext \nFinding more information and committee details \nUpdate information\n\nAssess the extent of deep endometriosis involving the bowel, bladder, or ureter. Ensure that pelvic MRI scans are interpreted by a healthcare professional with specialist expertise in gynaecological imaging. Consider laparoscopy to diagnose endometriosis in women with suspected endometriosis, even if the ultrasound was normal. For women with suspected deep endometriosis involving the bowel, bladder, or ureter, consider a pelvic ultrasound or MRI before an operative laparoscopy. During a diagnostic laparoscopy, a gynaecologist with training and skills in laparoscopic surgery for endometriosis should perform a systematic inspection of the pelvis. Consider taking a biopsy of suspected endometriosis during a diagnostic laparoscopy. Offer endometriosis treatment according to the woman's symptoms, preferences, and priorities rather than the stage of the endometriosis. Consider outpatient follow-up for women with confirmed endometriosis, particularly women with deep endometriosis involving the bowel, bladder, or ureter or large endometrioma. For women with endometriosis-related pain, discuss the benefits and risks of analgesics. Consider hormonal treatment for women with suspected, confirmed, or recurrent endometriosis. Discuss surgical management options with women with suspected or confirmed endometriosis. Perform surgery for endometriosis laparoscopically unless there are contraindications. Consider excision rather than ablation to treat endometriomas. Offer excision or ablation of endometriosis plus adhesiolysis for endometriosis not involving the bowel, bladder, or ureter to improve the chance of spontaneous pregnancy. Offer laparoscopic ovarian cystectomy or drainage and ablation to improve the chance of spontaneous pregnancy in women with endometriomas. Discuss the benefits and risks of laparoscopic surgery as a treatment option for women with deep endometriosis trying to conceive. Do not offer hormonal treatment alone or in combination with surgery to women trying to conceive as it does not improve spontaneous pregnancy rates. Terms used in this guideline: Chronic pelvic pain, Paediatric and adolescent gynaecology service, Ovarian cystectomy, Managed clinical networks. Recommendations for research: Pain management programs - Are pain management programs a clinically and cost-effective intervention for women with endometriosis?\n\nProvide an additional or alternative treatment option for women experiencing endometriosis-related pain. Groups of particular interest are women for whom hormonal and surgical options have been exhausted, women who would prefer an alternative to a pharmacological or surgical approach, and women who may be prioritizing trying to conceive.\n\nIs laparoscopic treatment (excision or ablation) of peritoneal disease in isolation effective for managing endometriosis-related pain? Isolated peritoneal endometriosis can be an incidental finding in women who may or may not experience pain or other symptoms. Research is needed to determine whether laparoscopic treatment of isolated peritoneal endometriosis in women with endometriosis-related pain results in a clinical and cost-effective improvement in symptoms.\n\nAre specialist lifestyle interventions (diet and exercise) effective, compared with no specialist lifestyle interventions, for women with endometriosis? Endometriosis is a long-term condition that can cause acute and chronic pain, and fatigue. It has a significant and sometimes severe impact on the woman's quality of life and activities of daily living, including relationships and sexuality, ability to work, fertility, fitness, and mental health.\n\nWhat information and support interventions are effective to help women with endometriosis deal with their symptoms and improve their quality of lives? This guideline has identified that women with endometriosis and their partners feel that information and support is not always provided in the way that best meets their needs. However, the direct effectiveness of different types or formats of information and support interventions on measurable outcomes such as health-related quality of life and level of function has not been tested.\n\nWhat is the effect of different doses and durations of hormonal treatments given either before, after, or both before and after surgery on fertility outcomes in people with endometriosis where fertility is a priority?",
  "system_prompt": "You are a medical guidelines compliance checker. Your task is to analyze if the given clinical note follows the specified guideline and suggest improvements.",
  "guideline_id": "nice-guidance-2024-endometriosis-pdf",
  "guideline_title": "NICE Guidance - 2024 - Endometriosis.pdf"
}

A: Here is the analysis of the clinical note against the NICE 2024 Endometriosis guideline, with recommendations for improvement:

### Very Important Recommendations  
1. **[Different management plan]** - **Consider MRI pelvis now (not just if pain persists) to assess for deep endometriosis involving bowel/bladder/ureter**  
Reason: NICE recommends assessing extent of deep endometriosis with specialist-interpreted imaging (pelvic MRI or ultrasound) before operative laparoscopy for suspected deep endometriosis (Section 1.5). Given this patient's history of Stage II endometriosis and worsening symptoms, MRI should be prioritized.  

2. **[Additional information needed]** - **Document whether patient is currently trying to conceive, as this significantly impacts management options**  
Reason: NICE emphasizes tailoring treatment based on fertility priorities (Section 1.11). Hormonal treatment alone is not recommended for women trying to conceive, and surgical approaches differ.  

### Somewhat Important Recommendations  
1. **[Improved patient advice]** - **Provide detailed information about all hormonal options (POP, Mirena IUS, GnRH analogues) including efficacy, side effects, and impact on fertility**  
Reason: NICE stresses discussing benefits/risks of all options based on patient preferences (Section 1.8, 1.10). The note mentions hormonal suppression but lacks shared decision-making details.  

2. **[Different management plan]** - **Explicitly consider excision (not ablation) if endometrioma found on future imaging**  
Reason: NICE recommends excision over ablation for endometriomas to improve pregnancy chances (Section 1.10). This should be specified given her reproductive age.  

3. **[Additional information needed]** - **Assess for bowel/bladder symptoms (e.g., dyschezia, hematuria) that may suggest deep infiltrating endometriosis**  
Reason: NICE requires evaluation of deep endometriosis symptoms (Section 1.3). The history focuses on pain but misses other key symptoms.  

### Less Important Recommendations  
1. **[Improved patient advice]** - **Provide written information/resources about endometriosis support groups and pain management programs**  
Reason: NICE highlights the need for information/support interventions (Research Recommendations). While not critical, this improves patient experience.  

2. **[Different management plan]** - **Consider earlier MDT involvement (pain team) given chronicity of symptoms**  
Reason: NICE recommends multidisciplinary care for complex cases (Section 1.1). Earlier input may prevent prolonged suffering.  

### Unimportant Recommendations  
1. **[Additional information needed]** - **Document migraine aura frequency/severity to better assess COCP contraindication**  
Reason: While relevant for hormonal options, this is less critical than fertility status or deep endometriosis evaluation.  

2. **[Improved patient advice]** - **Suggest specific dietary modifications for IBS/endometriosis overlap**  
Reason: NICE notes lifestyle interventions need more research (Research Recommendations). Current evidence is weak.  

Key Missing Elements per NICE:  
- No documentation of systematic laparoscopic inspection plan (should specify trained surgeon)  
- No discussion of fertility-preserving surgical options  
- Incomplete pain characterization (missing dyschezia/cyclic urinary symptoms)  

The note generally aligns well but would benefit from deeper endometriosis evaluation and more patient-centered counseling about long-term management options.

--- Token Usage Report ---
Prompt tokens: 2440
Completion tokens: 678
Total tokens: 3118
Estimated cost: $0.001559